These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 24722152)
21. A mass spectrometry assay to simultaneously analyze ROS1 and RET fusion gene expression in non-small-cell lung cancer. Wijesinghe P; Bepler G; Bollig-Fischer A J Thorac Oncol; 2015 Feb; 10(2):381-6. PubMed ID: 25384172 [TBL] [Abstract][Full Text] [Related]
22. A mouse model of KIF5B-RET fusion-dependent lung tumorigenesis. Saito M; Ishigame T; Tsuta K; Kumamoto K; Imai T; Kohno T Carcinogenesis; 2014 Nov; 35(11):2452-6. PubMed ID: 25064355 [TBL] [Abstract][Full Text] [Related]
23. Comparison of the breakpoint regions of ELE1 and RET genes involved in the generation of RET/PTC3 oncogene in sporadic and in radiation-associated papillary thyroid carcinomas. Bongarzone I; Butti MG; Fugazzola L; Pacini F; Pinchera A; Vorontsova TV; Demidchik EP; Pierotti MA Genomics; 1997 Jun; 42(2):252-9. PubMed ID: 9192845 [TBL] [Abstract][Full Text] [Related]
24. RET fusion genes in Korean non-small cell lung cancer. Yoo SS; Jin G; Jung HJ; Hong MJ; Choi JE; Jeon HS; Lee SY; Lim JO; Park JY J Korean Med Sci; 2013 Oct; 28(10):1555-8. PubMed ID: 24133367 [TBL] [Abstract][Full Text] [Related]
25. WAC/RET: A Novel RET Oncogenic Fusion Variant in Non-Small Cell Lung Carcinoma. Velcheti V; Madison R; Ali SM; Schrock AB J Thorac Oncol; 2018 Jul; 13(7):e122-e123. PubMed ID: 29935851 [No Abstract] [Full Text] [Related]
26. Identifification of a novel LDLR-RET Fusion in Lung Adenocarcinoma. Shi G; Luo Y; Yu Z; Wang Y; Zhu B Invest New Drugs; 2022 Aug; 40(4):858-860. PubMed ID: 35524867 [TBL] [Abstract][Full Text] [Related]
27. Oncogenic Function of a KIF5B-MET Fusion Variant in Non-Small Cell Lung Cancer. Gow CH; Liu YN; Li HY; Hsieh MS; Chang SH; Luo SC; Tsai TH; Chen PL; Tsai MF; Shih JY Neoplasia; 2018 Aug; 20(8):838-847. PubMed ID: 30015159 [TBL] [Abstract][Full Text] [Related]
28. Analysis of Cell-Free DNA from 32,989 Advanced Cancers Reveals Novel Co-occurring Activating Rich TA; Reckamp KL; Chae YK; Doebele RC; Iams WT; Oh M; Raymond VM; Lanman RB; Riess JW; Stinchcombe TE; Subbiah V; Trevarthen DR; Fairclough S; Yen J; Gautschi O Clin Cancer Res; 2019 Oct; 25(19):5832-5842. PubMed ID: 31300450 [TBL] [Abstract][Full Text] [Related]
29. RET rearrangements in lung adenocarcinoma and radiation. Dacic S; Luvison A; Evdokimova V; Kelly L; Siegfried JM; Villaruz LC; Socinski MA; Nikiforov YE J Thorac Oncol; 2014 Jan; 9(1):118-20. PubMed ID: 24346100 [TBL] [Abstract][Full Text] [Related]
30. [The progress of KIF5B-RET fusion gene in non-small cell lung cancer]. Jin LL; Kong H; Xie WP Zhonghua Jie He He Hu Xi Za Zhi; 2013 Jul; 36(7):524-6. PubMed ID: 24262090 [No Abstract] [Full Text] [Related]
31. Multiplex reverse transcription-PCR screening for EML4-ALK fusion transcripts. Takeuchi K; Choi YL; Soda M; Inamura K; Togashi Y; Hatano S; Enomoto M; Takada S; Yamashita Y; Satoh Y; Okumura S; Nakagawa K; Ishikawa Y; Mano H Clin Cancer Res; 2008 Oct; 14(20):6618-24. PubMed ID: 18927303 [TBL] [Abstract][Full Text] [Related]
32. REToma: a cancer subtype with a shared driver oncogene. Kohno T; Tabata J; Nakaoku T Carcinogenesis; 2020 Apr; 41(2):123-129. PubMed ID: 31711124 [TBL] [Abstract][Full Text] [Related]
33. Detection of EML4-ALK fusion genes in non-small cell lung cancer patients with clinical features associated with EGFR mutations. Shaozhang Z; Xiaomei L; Aiping Z; Jianbo H; Xiangqun S; Qitao Y Genes Chromosomes Cancer; 2012 Oct; 51(10):925-32. PubMed ID: 22736493 [TBL] [Abstract][Full Text] [Related]
34. HIP1-ALK, a novel fusion protein identified in lung adenocarcinoma. Hong M; Kim RN; Song JY; Choi SJ; Oh E; Lira ME; Mao M; Takeuchi K; Han J; Kim J; Choi YL J Thorac Oncol; 2014 Mar; 9(3):419-22. PubMed ID: 24518094 [TBL] [Abstract][Full Text] [Related]
35. Four novel RET germline variants in exons 8 and 11 display an oncogenic potential in vitro. Muzza M; Cordella D; Bombled J; Bressac-de Paillerets B; Guizzardi F; Francis Z; Beck-Peccoz P; Schlumberger M; Persani L; Fugazzola L Eur J Endocrinol; 2010 Apr; 162(4):771-7. PubMed ID: 20103606 [TBL] [Abstract][Full Text] [Related]
36. CD74-ROS1 fusion transcripts in resected non-small cell lung carcinoma. Matsuura S; Shinmura K; Kamo T; Igarashi H; Maruyama K; Tajima M; Ogawa H; Tanahashi M; Niwa H; Funai K; Kohno T; Suda T; Sugimura H Oncol Rep; 2013 Oct; 30(4):1675-80. PubMed ID: 23877438 [TBL] [Abstract][Full Text] [Related]
37. Papillary thyroid carcinoma: 6 cases from 2 families with associated lymphocytic thyroiditis harbouring RET/PTC rearrangements. Mechler C; Bounacer A; Suarez H; Saint Frison M; Magois C; Aillet G; Gaulier A Br J Cancer; 2001 Dec; 85(12):1831-7. PubMed ID: 11747322 [TBL] [Abstract][Full Text] [Related]
38. A novel RET fusion in non-small cell lung cancer identified by next-generation sequencing: a case report. Xu X; Wang H; Yu Z; Chen X J Cancer Res Clin Oncol; 2022 Jul; 148(7):1825-1827. PubMed ID: 35364706 [TBL] [Abstract][Full Text] [Related]
39. A novel PIBF1-RET gene fusion identified from a stage IA lung adenocarcinoma: A case report. Zhao W; Sun J; Zhu H; Zhao G Medicine (Baltimore); 2023 Jul; 102(29):e34305. PubMed ID: 37478265 [TBL] [Abstract][Full Text] [Related]
40. HOOK3-RET: a novel type of RET/PTC rearrangement in papillary thyroid carcinoma. Ciampi R; Giordano TJ; Wikenheiser-Brokamp K; Koenig RJ; Nikiforov YE Endocr Relat Cancer; 2007 Jun; 14(2):445-52. PubMed ID: 17639057 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]